|70 South Lake Avenue, Suite 930 , Pasadena, CA 91101|
|Fund Manager||J. Dale Harvey|
|Manager Tenure||11 Years 10 Months|
The Poplar Forest Partners Fund (the Partners Fund ) seeks to achieve long-term growth of capital. The Partners Fund seeks to deliver superior, risk-adjusted returns over full market cycles, by investing primarily in the common stocks of underappreciated companies and industries. A full market cycle is deemed to be a multi-year period including a period of material increase in the U.S. stock market (a bull market ) and a period of material decline in the U.S. stock market (a bear market ). The Fund generally focuses on 25 to 35 companies with (i) an investment grade debt rating, (ii) a history of paying common stock dividends, and (iii) a market capitalization among the top 1,000 companies in the United States. The Partners Fund is managed using a long-term approach to security selection. Investments will generally be made with an intended investment horizon of three years, although individual investments may be held for shorter or longer time periods. The Adviser evaluates investment opportunities using bottom up, fundamental analysis, paying particular attention to the following factors: expected future profits; expected sustainable revenue and/or asset growth; expected cash investment needed to support expected growth; normalized earnings and free cash flow after considering Items 1 through 3 above; and valuation relative to normalized earnings and free cash flow after giving consideration to growth potential and financial strength. The Partners Fund may also invest up to 25% of its net assets in government and corporate debt securities of any maturity. Of this 25%, no more than 10% of the Fund s net assets will be invested in investment grade corporate debt and no more than 5% of the Fund s net assets will be invested in non-investment grade (i.e., junk bonds) corporate debt. The Fund also may invest up to 20% of its net assets in foreign equity securities. Additionally, up to 15% of the Fund s net assets may be invested in a combination of convertible securities, options on stocks, warrants and rights and other non-money market fund investment companies.
|Asset Type||% Of Allocation|
|Total Net Assets||24.10 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$5000|
|Timeframe||Average Annual Current Performance Monthly As Of 09/30/2021||Average Annual Current Performance Quarterly As Of 09/30/2021||Avg Annual Current Performance Monthly As Of 09/30/2021||Avg Annual Current Performance Quarterly As Of 09/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|WFC||WELLS FARGO & CO||4.82%|
|ALLY||ALLY FINANCIAL INC||4.55%|
|AAP||ADVANCE AUTO PARTS||4.55%|
|MUR||MURPHY OIL CORP||4.30%|
|CVS||CVS HEALTH CORP||4.28%|
|EQH||EQUITABLE HOLDINGS INC||4.28%|
|NFG||NATIONAL FUEL GAS CO||4.16%|
|DXC||DXC TECHNOLOGY COMPANY||4.08%|
Master The Market with the Help of Our Financial Experts
Atea Pharmaceuticals could shed more than $2 billion in value Tuesday after the drugmaker said a mid-stage trial of its developing COVID treatment failed to meet expectations.
Cloud-software growth stocks have been a bright spot in an uncertain market. Investors might look closely at Cloudflare and Digital Ocean.
Philip Morris posts a third-quarter earnings beat as sales of its smokeless non-tobacco products continue strong, though cautions on supply chain impact.
Travelers Companies posts third-quarter earnings that exceed analysts’ forecasts as a drop in what it calls ‘catastrophic losses’ offsets record net written premiums.
Solid third quarters continue to power stocks higher Tuesday, even as growth and inflation signals remain stubbornly persistent as oil prices top $85 a barrel in overnight trading.
Procter & Gamble held its 2022 forecasts in place, seeing sales growth of between 2% and 4%, following stronger-than-expected first quarter earnings.
Johnson & Johnson said it sees 2021 vaccine sales of $2.5 billion, with overall revenues rising to between $94.1 billion to $94.6 billion, following its Q3 earnings beat.
Stocks edge higher ahead of earnings; SEC says GameStop surge powered by believers; FDA set to approve "mix & match' COVID boosters; DraftKings faces Entain bid deadline and Rent the Runway seeks $1.3 billion valuation in Nasdaq IPO.